RA
Taking the RA Threat to Heart During Pregnancy
Obesity, gestational diabetes mellitus and acute cardiovascular complications are more common among pregnant women ...
NOVEMBER 20, 2024
JAK Inhibitors, IL-6 Blockers for COVID-19: Where Do They Fit?
Another JAK inhibitor appears effective in reducing death and respiratory failure in patients hospitalized with ...
JULY 7, 2021
COVID-19 Vaccine Guidelines Address Special Considerations for Rheumatology Patients
The American College of Rheumatology (ACR) recently released recommendations for vaccinating rheumatology patients ...
JUNE 23, 2021
FDA Warns of Possible Serious CV Events, Cancer Linked to Xeljanz
The FDA issued an alert concerning an increased risk for serious cardiovascular events and malignancies with the ...
FEBRUARY 5, 2021
FDA Approves Rinvoq for Moderate to Severe RA
The FDA approved Rinvoq, a 15-mg, once-daily oral JAK inhibitor, for the treatment of certain adults with ...
AUGUST 27, 2019
